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Objective. The objective of this study was to test the efficacy of the Healing Pathways (HP) program in reducing clinically significantly
depressive symptoms in women with physical disabilities (WPD). Healing Pathways is a peer-implemented group mental health
treatment program targeting WPD who have clinically significant cooccurring depressive symptoms. Participants. Eighty women
were randomized in this trial. Design. This study used a community-based participatory intervention research design. Using
community-based recruiting methods, participants were recruited from Centers for Independent Living, local disability service
organizations, via Craig’s list as well as other community locations such as grocery stores and bus stops. Women participated in the
HP program for 14 weeks. Results. The primary outcome variable for this study was reduction in depressive symptoms as measured
by the Center for Epidemiologic Depression Scale (CES-D). We found that there was a significant interaction effect of treatment
by time on depression scores, F(3,210) = 9.51, 𝑃 < 0.0001, partial 𝜂2 = 0.101. Investigation of the predicted mean profile over time
in the intervention group demonstrated that depression scores decreased greatly from baseline to the first posttest and remained
stable in the two followups, whereas there was a little change in the mean profile over time in the control group. Conclusion. The
HP program has demonstrated initial efficacy in reducing depressive symptoms in women with physical disabilities.

1. Introduction
Women are at least twice as likely as men to experience a
major depressive episode once in their lifetimes and approximately 70% of the prescriptions written for antidepressants
are given to women [1]. The reasons for gender disparities in
depression rates include the influence of sex hormones, and
the incidence of serious adverse life events such as childhood
and adult sexual abuse and male partner violence [2, 3]. Even
in the absence of physical disability, depression significantly
impairs women’s social and physical functioning [1, 2].
Because many women with physical disabilities (WPD) have
poorer health than nonphysically disabled women, they often
have fewer reserves to compensate for depressive symptoms
[4–6]. Thus, when depression and physical disability cooccur,
the effects are usually most severe.

Depression negatively affects almost every conceivable
outcome for women with physical disabilities (WPD), from
physical health and functioning to employment, quality of
life, and mortality [7–15]. This is alarming since women with
physical disabilities WPD experience clinically significant
depressive symptoms at high rates and may face barriers
to accessing needed care. In a study of 443 WPD, Hughes
and colleagues found that 51% of the sample had scores
signifying mild depression or higher on the Beck Depression
Inventory (BDI) [4, 16]. Of those women who were depressed,
only 44% had been able to access treatment within the
past three months [4]. In a second study of 64 women
living with spinal cord injury for at least two years, Hughes
and colleagues found that 59.1% of women had clinically
significant depressive symptoms as measured by the Center
for Epidemiologic Studies Depression Scale (CES-D) [7, 17].
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In our study of abuse and health in men and women with
spinal cord injury or dysfunction, 53% of our sample of
165 women had clinically significant depressive symptoms as
measured by the CES-D [18].
Consistent with findings cited above, Hughes and colleagues study of 134 depressed WPD found that more than a
third of the women had received no treatment for depression
within the past three months [19]. Barriers to accessing
mental health care that WPD may face include physical illness, transportation, accessibility, and poverty [19]. Another
important barrier is the lack of mental health treatment programs available that address the experience of cooccurring
physical disability and depression. Although a small number
of programs focus on depression as a primary outcome [20–
25], we found only one published paper describing a program
that builds on WPD’s shared experiences and the strengths of
disability communities [20].
Although WPD are a diverse group, there are some common variables of interest that are associated with depressive
symptoms. Coping and health behaviors have been widely
cited as important constructs for WPD in terms of their overall health and well-being and the prevention and amelioration
of secondary conditions like depression [5, 26–29]. Active
coping [26], spirituality, interpersonal relations, and stress
management in particular have been mentioned [5]. Selfesteem both as a global construct and specific to a woman’s
body and sexuality have also been identified as important for
understanding depressive symptoms. According to Hughes
and colleagues, “lowered self-esteem is a common feature of
depression” in WPD [30, page 296]. In their study to determine the efficacy of a 6-week self-esteem group intervention
for WPD, they found that self-esteem mediated the effect
of the intervention on depression [30]. In a study of body
and sexual self-esteem, Taleporos and McCabe sampled 1196
participants including 748 persons with physical disabilities
and 448 persons without physical disabilities [31]. They found
that sexual and body esteem were strong predictors of selfesteem and depression in people with physical disabilities and
that this effect was stronger among people with disabilities
than in people without disabilities. Loneliness or social
participation has also been identified as an important variable
related to depression in WPD [32, 33]. In a study of the
relevance of depressive symptoms and social support to
disability in women with multiple sclerosis (𝑛 = 118) and
fibromyalgia (𝑛 = 197), Phillips and Stuifbergen found that
social support had a large protective effect on depressive
symptoms [33]. The authors noted that interventions that
promote social connection may particularly be important for
WPD.
To help address the serious problem of depression in
WPD, to expand available treatment options, and to increase
access to affordable treatment we developed and tested the
Healing Pathways program using a community-based participatory research design (CBPR). Healing Pathways (HP) is a
cross-disability peer implemented strengths-based cognitive
behavioral group treatment program. To assess the efficacy
of the HP program we conducted a study in partnership
with three grass roots consumer-run disability service agencies. The purpose of CBPR is to engage researchers and
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community members as equal partners to create knowledge
that is directly applicable and available to communities, especially those who have historically experienced social and economic marginalization [34, 35]. Our academic-community
partnership grew out of ten years of community-placed
work and one previous CBPR project. Guiding principles
of our collaboration included accessibility to all aspects of
the projects across physical disability types and collaborative
development of interventions that enable community control
over future implementation. See Hassouneh et al. [36] for
more information about the HP partnership and the CBPR
methodology employed.

2. Study Aims
The aims of the study were to (1) modify an existing
group therapy intervention to address the specific needs of
WPD who experience depressive symptoms [37] and to (2)
conduct an efficacy trial of the modified intervention. We
hypothesized that WPD receiving the HP program would
demonstrate greater improvement in our primary outcome
variable depressive symptoms than WPD in the wait-list
control group. We also hypothesized that WPD receiving the
HP program would demonstrate greater improvement in
our secondary outcome variables, coping, health behavior,
global self-esteem, body image and sexual self-esteem, and
loneliness, compared to WPD in the wait-list control group.
Finally we asked the following research question: what are the
relative contributions of changes in coping, health behavior,
global self-esteem, body image and sexual self-esteem, and
loneliness to changes in depressive symptoms?

3. Method
3.1. Participants. We screened a total of 101 women and
enrolled 89 WPD of age 19–81. Nine women were ineligible
and three declined to enroll. Of the 89 WPD enrolled we
randomized 80; 44 were assigned to the intervention group
and 36 to the wait-list control group. Nine women dropped
out prior to the time when randomization occurred due to
reasons of illness and moving away. We assessed depressive
symptom scores during the initial screening interview using
the CES-D. Inclusion criteria for study enrollment included
(1) self-reported physical disability requiring some form of
disability accommodation and support; and (2) a CES-D
score of 16 or higher at the time of enrollment. Exclusion
criteria included (1) significant self-reported intellectual disability and/or receipt of developmental disability services; (2)
active suicidality; (3) current receipt of other psychotherapy
services; and (4) current psychosis. Significant self-reported
intellectual disability was ascertained by asking the following
two questions: (1) do you have a guardian? and (2) are
you receiving development disability services for a cognitive
disability? These criteria allowed for inclusion of a wide
variety of WPD often with multiple cooccurring conditions.
All participants enrolled in the study who completed baseline
data were included in the analysis.
The demographic and disability-related characteristics of
the participants are presented in Table 1. As presented in the

Rehabilitation Research and Practice

3
Table 1

Categorical variables
Ethnicity
African American/black
Unknown
Asian
Hispanic
Multiracial
White
Native American
Employment
(1) No
(2) Yes
Marital status
Single
Married, living together
Income
$0 to $30,000
$31,000 to $50,000
$51,000 to $70,000
$71,000 to $101,000
Disability severity
1
2
3
Receive assistance from others
(1) No
(2) Yes
Continuous variables
Age
Education
Primary disability
Arthritis, other musculoskeletal disorders (yes)
Neurological disorder (yes)
Others (yes)
∗

Demographic Characteristics
Intervention
Control
𝑁 (%)
𝑁 (%)

All
𝑁 (%)

𝑃 value

2 (4.55%)
0 (0%)
0 (0%)
0 (0%)
7 (15.91%)
33 (75%)
2 (4.55%)

0 (0%)
3 (8.57%)
1 (2.86%)
2 (5.71%)
2 (5.71%)
27 (77.14%)
0 (0%)

2 (2.53%)
3 (3.8%)
1 (1.27%)
2 (2.53%)
9 (11.39%)
60 (75.95%)
2 (2.53%)

0.82∗

36 (81.82%)
8 (18.18%)

22 (62.86%)
13 (37.14%)

58 (73.42%)
21 (26.58%)

0.058

34 (79.07%)
9 (20.93%)

21 (60%)
14 (40%)

55 (70.51%)
23 (29.49%)

0.0662

36 (81.82%)
5 (11.36%)
2 (4.55%)
1 (2.27%)

28 (80%)
3 (8.57%)
3 (8.57%)
1 (2.86%)

64 (81.01%)
8 (10.13%)
5 (6.33%)
2 (2.53%)

0.338∗

1 (2.27%)
14 (31.82%)
29 (65.91%)

1 (2.86%)
18 (51.43%)
16 (45.71%)

2 (2.53%)
32 (40.51%)
45 (56.96%)

0.15

6 (13.64%)
38 (86.36%)
Mean ± SD
51.59 ± 10.18
14.02 ± 2.24
Intervention
𝑁 (%)
32 (71.11%)
11 (24.44%)
21 (46.67%)

2 (5.56%)
34 (94.44%)
Mean ± SD
52.09 ± 10.9
14.17 ± 2.32
Wait-list
𝑁 (%)
21 (56.76%)
13 (35.14%)
15 (40.54%)

8 (10%)
72 (90%)
Mean ± SD
51.81 ± 10.44
14.09 ± 2.26
All
𝑁 (%)
53 (64.63%)
24 (29.27%)
36 (43.9%)

0.28

0.82
0.77

0.18
0.29
0.58

is performed on the regrouped categories. See the text for more details.

table the majority of participants were European-American
(75.95%), employed (73.42%), and single (70.51%) with a
household income of less than $20,000 per year (81.01%).
With regard to disability 64.63% reported having arthritis or
other musculoskeletal disorders, 29.27% reported having a
neurological disorder, and 43.9% reported having some other
kind of condition. The majority of participants rated their
disabilities as moderate (40.51%) or severe (56.76%). Ninety
percent of participants reported receiving assistance from
others to help them with activities they would normally be
able to do themselves if they did not have a disability.
3.2. Description of the HP Program. The HP program is
a manualized strengths-based cognitive behavioral group

therapy program designed to be implemented by two peers.
Program materials include a women’s workbook and a facilitator manual. The final version of the program includes 14
sessions each of 2.5 hours in length. The PI assumed primary
responsibility for development of the HP program in collaboration with WPD from Oregon disability communities
over the course of two CBPR projects [36]. Development
of the HP program was informed by a complete literature
review, a series of focus groups, input from an advisory
board, and written contributions from WPD community
members. The HP program promotes self-empowerment
through skill building in four core areas (1) identifying and
addressing thoughts and beliefs; (2) identifying and managing emotions; (3) improving interpersonal skills; and (4)
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developing and strengthening coping and problem-solving
skills. The principles underlying cognitive behavioral therapy
and strengths-based approaches to promoting healing and
personal growth are woven throughout each of these areas
and the entire program. Healing Pathways session topics
include: (1) introduction to the program and overview of
depression in WPD; (2) strengths and goals; (3) mental habits;
(4) understanding and managing emotions; (5) sense of self
(includes optional content on body image and sexuality); (6)
personal identity and role models; (7) violence and abuse;
(8) relationships, social support, and physical disability; (9)
developing communication skills; (10) stress and coping; (11)
wellness; and (12) moving forward.
3.3. Procedures
3.3.1. Selection of Sites. There were two urban and two
rural partners in this project. Our originally urban HP
partnership evolved primarily from preexisting partnerships
that had developed over time through work on a previously
completed community-based participatory research project
as well as other community-placed research projects. We
added rural partners to broaden the impact of our findings.
Characteristics sought among partners were commitment to
Independent Living Philosophy, a track record of reliability,
and commitment to the goals of the project. Community buyin was also assessed as part of the selection process through
a series of meetings with local leaders. Existing team leaders
met to discuss potential new partners and selection decisions
were made by consensus.
3.3.2. Team Training. We provided a 10-day face-to-face
training that included all components necessary for completing the project. Team members attended only those
components of the training that were relevant to their roles.
All team members received training on research ethics, the
importance of confidentiality of participants and data, safety,
and guidelines for recruiting.
Community partners identified two WPD peer facilitators who would be trained to implement HP groups. In
addition to the 10-day face-to-face training series we also
provided additional site specific face-to-face and telephone
training support as needed as part of peer facilitator training.
Training specific to implementation of groups included the
following areas: understanding depression and anxiety; crisis
intervention; suicide assessment and intervention; violence
and abuse assessment and intervention; and responding
to trauma. Peer facilitators also learned about the concept
of fidelity and reviewed study procedures for facilitator
adherence and competence. Methods of training included
instructional videos, self-paced readings, and face-to-face
training with mock sessions and role plays. Training was
provided by persons from the disability community with
recognized expertise in specific areas as well as by Psychiatric
Mental Health Nurse Practitioners.
Each community partner identified two to three data
collectors to conduct the screening and enrollments and
complete data collection interviews. These team members
received training guidelines for how to screen and enroll

Rehabilitation Research and Practice
participants including informed consent procedures. Team
members demonstrated proficiency conducting three mock
screening and enrollment interviews prior to starting actual
data collection. We reviewed and practiced safety protocols
in detail, often using role play scenarios. We also reviewed
protocols related to maintaining follow-up contact with participants in-between time points. Participants who required
additional support were provided with one-on-one tutoring
until they mastered all content.
3.3.3. Supervision of Lay Leaders. Peer facilitators received
clinical supervision as a group for two hours each week
with a highly experienced doctorally prepared Psychiatric
Mental Health Nurse Practitioner throughout the duration
of the intervention period. This clinical supervisor was also
available for additional consults as needed throughout the
week. In addition, the PI, also a Psychiatric Mental Health
Nurse Practitioner, was available for emergency consults
seven days a week.
3.3.4. Research Fidelity. We developed tools for measuring
intervention fidelity for use specific to this project. These
tools included (1) a session specific adherence checklist which
included a time measurement index for core elements in
each session and (2) a facilitator competence measure. We
developed session specific adherence checklists by mapping
activities from the facilitator manual. To develop the facilitator competence measure we conducted a literature search
for the purpose of identifying existing reliable and valid
competence measures. Once we had identified measures
with the greatest applicability to the HP curriculum we
then adapted items from these existing scales to create the
Healing Pathways facilitator competence measure. Next, we
pilot tested the competence measure using two independent
coders who coded three audio recorded practice sessions.
To assess the fidelity of actual group sessions we randomly
selected groups for coding each week of the 14-week program.
Two independent coders listened to audio recordings of these
sessions. Coding was subsequently discussed with the PI.
In addition, to elicit qualitative data relevant to intervention fidelity and quality, we asked both coders and group
facilitators to complete a narrative for each session. While
relevant to intervention fidelity, we used this qualitative
information primarily as a means of assessing the quality
of sessions, thereby providing a feedback loop for quality
improvement. Using these methods of measurement we
implemented the HP program with a facilitator adherence of
87% and competence of 2.79 (3 point scale, 3 = most, and 1 =
least competent).
3.3.5. Recruitment. All study activities and procedures were
approved by the University Internal Review Board. We also
obtained a Certificate of Confidentiality from the Department of Health and Human Services to provide additional
protection to participants. We used detailed protocols to
ensure the safety of participants including protocols addressing suicidal ideation and violence and abuse. All collaborating
partners recruited participants for the study using a variety
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of strategies. We used a flier describing the study and its
target population of “women with physical disabilities who
have depressive symptoms” as part of our recruitment efforts.
Thus, participants who responded to the fliers self-selected
based on their perception of themselves as women who
experienced both physical disability and depression. Our
recruitment strategies included a direct mailing via a durable
medical equipment mailing list, advertisements on Craig’s
List, and active community recruiting at places such as
grocery stores, bus stops, and local disability interest groups
including the Multiple Sclerosis Society and United Cerebral
Palsy.
In addition to recruiting, each collaborating partner was
involved in screening and enrolling participants for the study.
We used a two-step informed consent process at screening and enrollment interviews. First we obtained consent
for screening and completed screenings. We then obtained
consent for enrollment and completed enrollment interviews
for those women who were deemed eligible and wanted to
participate. Screening and enrollments took place either at
the local community partner offices or at a location of the
participants’ choosing.
After recruitment, screening and enrollment processes
were completed we randomized participants to the intervention or a wait-list control group. We used SPSS as the
method of random assignment. The wait-list control group
was smaller than the initial group to minimize the number
of women who would have to wait for receipt of mental
health services as a result of study participation. Women
were notified of their random assignment by the same team
member who had conducted their screening interviews either
in person or over the phone.
3.3.6. Data Collection. We used face-to-face interviews to
collect data. Instruments were completed by interviewers
who had participated in the aforementioned 10-day training.
Participants randomized to the initial treatment group participated in data collection interviews for time points 1–4.
During this same time period participants randomized to the
wait-list control group completed identical pre- and posttests
without participating in the intervention. Participants randomized to the wait-list control group then participated in
a different version of the HP program and participated in an
additional three data collection time points (time points 5–
7). Because we tested two different versions of the program,
we have chosen not to combine the results. Therefore we
report on time points 1–4 here. Accordingly for the purposes
of this paper the wait-list control group is hereafter referred to
simply as the control group. The four time points reported on
here include the pretest (time point 1), a posttest conducted
immediately upon completion of the HP program (time
point 2), six-week postintervention (time point 3), and threemonth postintervention (time point 4).

4. Outcomes and Measures
All outcome variables and covariates were derived primarily
from discussions among the HP partners and a review of
empiric literature. We selected our measures and the specific
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subscales used from those measures based on the goals and
outcomes of the HP program including the skill-building
focus of the four core areas described above. Our primary
outcome measure of depressive symptoms, our secondary
outcome measures of coping, health behavior, global selfesteem, body and sexual-self-esteem, and loneliness, and our
measures of covariates are described below.
4.1. Depressive Symptoms. We measured our primary outcome variable of depressive symptoms using the Center for
Epidemiologic Depression Scale (CES-D). The CES-D is a
20-item measure that assesses mood during the past week
using a 4-point Likert scale ranging from 0 = rarely or none
(less than a day) to 3 = most or all of the time (5 days).
Four of the 20 items are reverse scored, and the total measure
is scored by summing all items. A score of 16 or greater
signals possible depression. The CES-D has demonstrated
excellent reliability with Cronbach’s alphas ranging from 0.85
in community samples to 0.90 in psychiatric samples [38]. In
a previous study we conducted with 165 WPD we used the
CES-D and obtained a Cronbach’s alpha of 0.92 [39].
4.2. Coping. We measured coping using selected sub-scales
of the Brief COPE. The Brief COPE contains 30 items to
assess a broad range of coping and problem-solving responses
with 14 two-item sub-scales. The inventory includes some
responses that are expected to be dysfunctional, as well as
some that are expected to be functional. We selected six of the
14 sub-scales for use based on their relevance to HP program
core skill areas. These include substance abuse, emotional
support, positive reframing, self-blame, active coping, and
instrumental support. The COPE has been used in previous
studies with WPD [29, 40] as well as with depressed women
[41]. For each item, the respondent is asked to indicate the
frequency of each behavior/thought process, ranging from 1 =
I usually do not do this at all to 4 = I usually do this a lot. The
subscales are scored using the mean of 4 items. Cronbach’s
alphas for COPE subscales range from 0.63 to 0.80 [41].
4.3. Health Behavior. We measured health behavior using
the Health Promoting Lifestyle Profile II (HPLP-II). The
HPLP-II is a 52-item global measure of health behavior. It
contains six subscales. We selected three of the six sub-scales
for use based on their relevance to HP program core skills
areas including spirituality, interpersonal relations, and stress
management. For each item, the respondent indicates the
frequency of each behavior ranging from 𝑁 for never (=1) to
𝑅 for routinely (=4). Scoring uses the mean of items on each
subscale. Cronbach’s alphas on HPLP-II subscales range from
0.69 to 0.86 [42, 43].
4.4. Rosenberg Self-Esteem Scale. We measured global selfesteem using the Rosenberg Self-Esteem Scale (RSES). The
RSES is a 10-item measure of one’s overall evaluation of the
self. The measure uses a 4-point Likert scale ranging from 3
= strongly agree to 0 = strongly disagree. The total measure
is scored by summing all items The RSES has been used with
WPD in other studies with Cronbach’s alphas reported from
0.70 to 0.90 [20].
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4.5. Body and Sexual Self-Esteem. We measured body and
sexual self-esteem using the Physical Disability Sexual and
body Esteem Scale (PDBSE). The PDBSE is a 10-item measure
of the capacity to feel positive about one’s sexuality and body
while living with a physical disability [31, 44]. The measure
uses a 4-point Likert scale ranging from 1 = strongly agree to
4 = strongly disagree. The total measure is scored by summing
all items. In our previous study with 165 WPD, we obtained a
Cronbach’s alpha of 0.90 [39].
4.6. Loneliness. We measured loneliness using the UCLA
Loneliness scale-Version 3 (UCLA-LS). The UCLA-LS is a
20-item scale that measures levels of loneliness in everyday
life. It includes 9 positive (nonlonely) and 11 negative (lonely)
items, randomly distributed throughout the instrument. Participants rate each item on a 4-point Likert scale ranging from
1 = never to 4 = always. The UCLA-LS has previously been
used successfully with WPD and women with depression
[45]. Nine of the items are worded positively and reversed
scored. The total measure is scored by summing all items.
Cronbach’s alpha for the scale range from 0.89 to 0.94 [46, 47].

5. Measurement of Covariates
Several studies have identified significant relationships
among pain, fatigue, and depressive symptoms in a variety
of populations. Specifically, it has been observed that severity
of depressive symptoms varies in proportion to the level of
pain and/or fatigue experienced [48–52]. Despite the wellestablished associations between pain, fatigue, and depressive
symptoms, it is not clearly understood how these variables
interact with physical disability [50, 52]. Substance abuse (as
an identified problem rather than as a coping style) has also
been shown to be both common in people with disabilities
[53] and associated with depression [54, 55]. Because these
variables could potentially influence depressive symptoms in
WPD, we included them in our analysis as covariates. Other
covariates include age group, socioeconomic status (SES), and
physical dependency. We used a demographic questionnaire
to collect data on age and SES. The remaining measures are
described below.
5.1. Physical Dependency. We measured physical dependency
using the Stanford Health Assessment Questionnaire (HAQ).
The HAQ is an 8-item measure of ability [56]. Participants
are asked to rate each item on a 4-point Likert scale ranging
from 0 = without difficulty to 3 = unable to do. The measure is
scored using the mean of 8 items. In our previous study with
165 WPD we obtained a Cronbach’s alpha of 0.92 [39].
5.2. Substance Abuse. We measured substance abuse using
the CAGE-AID. The CAGE-AID is a 4-item screening measure that has been used with WPD and depressed women
in numerous studies [57]. The CAGE-AID screens for alcohol or drug problems based on the CAGE alcohol screen.
Respondents are asked to answer 1 = yes and 0 = no to four
questions. The CAGE-AID is scored by counting the number
of items answered yes. Score of 1 = possible problem and 2
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= probable problem. The CAGE-AID has exhibited strong
sensitivity and specificity, ranging from 60 to 95% and from
40 to 95%, respectively [57, 58].
5.3. Pain and Fatigue. To assess pain and fatigue we used verbal rating scales (VRS) of which have been used extensively in
clinical practice and research with WPD [59–63]. Participants
were asked “On a 0 to 10 scale, where “0” equals no fatigue
and “10” equals the worst fatigue imaginable, how severe has
fatigue been, on average, during the past week?” The same
approach scale was used to assess pain. The VRS for fatigue’s
test-retest reliability is strong (0.93). Cronbach’s alpha of the
VRS for pain is 0.88 [63].
5.4. Statistical Analysis. We used SPSS 16.0 and SAS 9.2.2
to conduct our statistical analyses. We computed means,
standard deviations, and frequencies for numerical and categorical variables. At the baseline, we perform the comparison
for the group difference using Chi-square/Fisher’s Exact test
(for qualitative variables and two independent sample ttest/Wilcoxon Rank Sum test (for quantitative variables)
when appropriated. To test hypothesis (1) WPD receiving
the intervention will demonstrate a greater improvement in
depressive symptom scores compared to participants in the
control group, we used a mixed effects model in which the
outcome of interest is the depressive symptom score, the two
fixed-effects are group treatment effect with two levels (intervention versus control), and the time effect has four levels
(baseline, posttest, 6-week followup, and 3-month followup).
Subject specificity served as a random effect in this model.
An interaction treatment-by-time effect was examined to
test if the intervention improved the outcome of depressive
symptoms. Similarly, to test hypothesis (2) WPD receiving
the intervention will demonstrate a greater improvement in
coping, health behavior, global self-esteem, body image and
sexual self-esteem, and loneliness compared to participants
in the control group, we used a mixed effects model on
these secondary outcomes. Significant group-by-time interactions, such that the intervention group exhibited significant
improvement in the secondary outcomes compared to the
control group would provide support for hypothesis 2.
To address the research question: What are the relative
contributions of changes in coping, health behavior, global selfesteem, body image and sexual self-esteem, and loneliness to
changes in depressive symptoms? we applied a mixed effects
model in which the depressive symptom score is the outcome
of interest, and each secondary outcome served as a primary
predictor. We also included the group treatment, time, and
the interaction treatment-by-time in the model as adjusting
factors while examining the association. Those secondary
outcomes having a significant association with depressive
symptom scores were included in the multivariable model
for association testing. If slope testing for each of these
secondary outcomes was significant, an association between
the change in that particular secondary outcome and change
in depressive symptoms was established. We also included
age and SES in the model as adjusting covariates/factors. We
then compared the standardized estimates (slope coefficient
estimates) for each significant slope parameter to determine
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the relative strength of the secondary outcomes in predicting
changes in depressive symptoms.
We conducted a per protocol (PP) analysis using mixeddesign ANOVAs with complete data, and an intent-to-treat
(ITT) analysis using hierarchical linear modeling (HLM).
We found ITT provided us with greater power, for example, smaller 𝑃 values. In addition, with ITT, we examined
linear and quadratic terms of time effect and found that
the quadratic model did not capture the time effect, for
example, 𝑃 values > .05. In fact, we studied the overall (mean)
trajectories over time of the outcomes of interest and found
that the quadratic curve was not supportive. Taking all these
observations into account, to maximize all available data,
our analysis addressing aims 1 and 2, and research question
1 is based on a mixed effects model. To our knowledge,
this statistical method has been widely used in longitudinal
studies for the last several decades. The advantage of this
method is its flexibility in dealing with missing values; a
missing observation does not cause the deletion of other
observations from the same subject in the analysis. Thus, we
made use of all available data, capturing greater statistical
power for hypothesis testing.
Because mixed effects modeling is based on a maximum
likelihood approach, the quantity of sum of squares due to
each effect or error cannot be obtained. As such it is not
possible to compute partial 𝜂2 as an effect size measure with
this approach. Therefore to compute the effect size, we used
a general mixed ANOVA model. In sequence, this statistical
method was applied to each aim and research question
discussed in detail below. The level of significance of an effect
was tested at an alpha of 0.05. If the 𝑃 value of a test was
between 0.05 and 0.1, we considered that the effect had a trend
toward significance. Because we used a mixed effects model
in which a missing value of one observation does not cause
the deletion of the observed data of the related-subject from
the analysis and we had very few missing values, it was not
necessary to use an imputation technique.

6. Results
Our group retention rate was 81% overall, more specifically
95% in the intervention group; 67% in the control group. We
examined the distributions of age for each group, and the
assumption of normality was reasonably met. The means and
standard deviations were 51.59 ± 10.18 for the intervention
and 52.09 ± 10.90 for the control group. We performed a two
independent sample t-test as the comparison between the two
groups; there was no significant difference in age between the
intervention and control groups (𝑃 = 0.835). Participants’
age ranges were 28–80 and 19–71 in the intervention and
control groups, respectively. We used income as a proxy for
SES. To compare the distributions in SES between groups,
we subgrouped the number of categories to 3; specifically,
we kept the first two categories $0–$10,000 and $10,000–
$20,000 and created a new category for those whose salary
was greater than $20,000. We performed a Chi-square test
as the comparison between the two groups; there was no
significant difference in SES between the intervention and
control groups (𝑃 = 0.338). With regard to ethnicity, 75%
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(33/44) versus 77.14% (27/35) of the intervention versus the
control group, respectively, were European-American; there
was no significant difference between the two groups (𝑃 =
0.82). We also conducted further comparisons between the
two groups on the other characteristics/covariates, that is,
education (𝑃 = 0.77); employment (𝑃 = 0.06); marital
status (𝑃 = 0.07); disability severity (𝑃 = 0.15); and
receiving assistance from others (𝑃 = 0.28). Finally, 71% and
56% of participants in the intervention and control groups,
respectively, reported arthritis or musculoskeletal disorders
(𝑃 = 0.18), 24% and 35% reported neurological disorders
(𝑃 = 0.29), and 45% and 40% reported other conditions as
their disability types (𝑃 = 0.58). In summary, there was no
statistical significant difference in demographic and disability
characteristics between the intervention and control groups.
See Table 1 for more details.
We checked the range of values for the other variables
and found them to be in the reasonable range. Since the data
of our primary outcome (depressive symptoms), secondary
outcomes (coping sub-scales (substance abuse, emotional
support, positive reframing, self-blame, active coping, instrumental support), health behavior sub-scales (spirituality,
interpersonal relations and stress management), global selfesteem, body image and sexual-self-esteem, and loneliness),
and other covariates (physical dependency, substance abuse
problem, and pain and fatigue) were collected over time,
the distributions of each measure at each time point were
studied and are summarized in Tables 2(a) and 2(b). We
also performed a comparison between the two groups on
the primary outcome, depressive symptoms, at baseline and
found a significant difference (𝑃 = 0.04). As shown in Tables
2(a) and 2(b), the (mean ± sd) of depressive score of the
two groups at the pretest are 1.71 ± 0.52 versus 1.37 ± 0.5
for the intervention versus control group, respectively. These
mean scores indicate, on average, that the intervention group
had more severe depression (higher mean score) at baseline.
However, the situation was reversed at the final post-test;
that is, the depressive score was lower in the intervention
group (1.08 ± 0.64) compared to the control group (1.38 ±
0.5). This observation was confirmed with our testing for
the interaction between time and group treatment on the
depression measure outcome (see below).
Examination of the predicted mean curves over time
between the intervention and control groups suggests that
interaction effects occurred in depressive symptom score,
loneliness, body image and sexual self-esteem, substance
use, stress management, interpersonal relations, spirituality,
emotional support, positive reframing, and self-blame. We
did not identify interaction effects in active coping, instrumental support and global self-esteem (see Figure 1). These
suggestions were confirmed by testing for interaction terms
between time and group treatment as shown in Table 3.
Furthermore, in Figure 1, in the intervention group, we saw
a sharp increase/decrease from the pre-test (Time 0) to posttest (Time 1) and that this pattern was either continued or
stabilized at three-month followup (Time 4). This kind of
pattern occurred in most scales that showed the existence
of the aforementioned interaction. On the other hand, in
the control group, most mean curves were either flat or

Primary outcome
Depressive symptom score
Secondary outcome
(i) Coping and problem-solving
(a) Active coping
(b) Substance use
(c) Emotional support
(d) Instrumental support
(e) Positive reframing
(f) Self-blame

Measures

0.61
1.5
6.5

44
44
44

1.37

2.85
1.24
2.4
2.38
2.68
2.76

36
36
36
36
36
36

Time 0
Mean

0.8
0.6
0.8
0.9
0.9
1.1

0.5

2.4
2.57
2.25
2.77
2.48
24.25

44
44
44
44
44
44

SD

2.92
1.5
2.35
2.55
2.59
3.02

44
44
44
44
44
44

0.34
1.45
2.16

0.51
0.47
0.54
0.46
0.55
7.46

0.86
0.93
0.8
0.87
0.88
0.81

0.52

SD

33
33
33
33
33
33

33

2.94
1.3
2.38
2.47
2.67
2.56

1.38

0.9
0.8
1
1
1
1.1

0.5

Posttest
Time 1
𝑁 Mean SD

1.71

Pretest
Time 0
Mean

44

𝑁

Pretest

36

𝑁

Primary outcome
Depressive symptom score
Secondary outcome
(i) Coping and problem-solving
(a) Active coping
(b) Substance use
(c) Emotional support
(d) Instrumental support
(e) Positive reframing
(f) Self-blame
(ii) Health behavior
(a) Spirituality
(b) Interpersonal relation
(c) Stress management
(iii) Loneliness
(iv) Rosenberg global self-esteem
(v) Body Image and sexual self-esteem
Covariates
(i) Physical dependency
(ii) Substance abuse
(iii) Pain and fatigue

Measures

(b)

0.59
1.5
5.88

2.92
2.84
2.58
2.34
2.77
30.3

3.36
1.28
3.08
3.03
3.35
1.99

1.08

0.37
1.48
2.43

0.5
0.46
0.45
0.5
0.49
7.4

0.69
0.65
0.79
0.84
0.77
0.65

0.64

SD

42
42
42

42
42
42
42
42
42

42
42
42
42
42
42

42

𝑁

32
32
32
32
32
32

32

3.02
1.23
2.52
2.64
2.83
2.58

1.29

0.96
0.75
0.91
0.99
0.89
1.06

0.7

30
30
30
30
30
30

30

3
1.37
2.55
2.43
2.67
2.78

1.35

0.81
0.81
0.86
0.98
0.79
1.1

0.56

Control/nonintervention
6-week followup
3-month followup
Time 2
Time 3
𝑁 Mean
SD
𝑁 Mean
SD

40
40
40

40
40
40
40
40
40

39
39
40
40
40
40

40

𝑁

Posttest
Time 1
Mean

(a)

Table 2: (a) Intervention group, (b) wait-list group.

20
20
20
20
20
20

20

3.48
1.08
3.15
3.15
3.23
2.08

1.01

0.6
0.2
0.8
0.8
0.7
0.7

0.6

Posttest
Time 4
𝑁 Mean SD

0.59
1.33
5.83

2.94
2.98
2.67
2.3
2.79
30.21

3.18
1.18
2.92
2.75
3.26
2.08

1.03

41
41
41

41
41
41
41
41
41

41
41
41
41
41
41

41

𝑁

26
26
26
26
26
26

26

3.29
1.17
2.88
2.67
2.73
2.15

1.19

0.81
0.62
0.98
0.99
0.96
0.89

0.73

Intervention
6-week followup
Time 5
𝑁 Mean
SD

0.39
1.37
2.29

0.54
0.48
0.49
0.48
0.5
8.14

0.75
0.43
0.87
0.86
0.77
0.73

0.61

6-week followup
Time 2
Mean
SD

0.37
1.45
2.21

0.55
0.5
0.56
0.48
0.53
9.09

0.64
0.4
0.88
0.86
0.8
0.84

0.54

24
24
24
24
24
24

24

3.23
1.06
2.9
2.69
2.79
2.27

1.08

0.85
0.22
0.83
0.83
0.88
1.01

0.6

3-month followup
Time 6
𝑁 Mean
SD

0.6
1.29
5.78

2.98
2.96
2.67
2.26
2.78
30.39

3.35
1.17
2.88
2.83
3.29
2.05

0.99

3-month followup
Time 3
Mean
SD
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(ii) Health behavior
(a) Spirituality
(b) Interpersonal relation
(c) Stress management
(iii) Loneliness
(iv) Rosenberg global self-esteem
(v) Body Image and sexual self-esteem
Covariates
(i) Physical dependency
(ii) Substance abuse
(iii) Pain and fatigue

Measures

2.66
2.7
2.25
2.65
2.4
27.11
0.72
1.67
6.22

36
36
36
36
36
36
36
33
36

𝑁
33
33
33
33
33
33

0.6 33
1.5 31
2.1 33

0.6
0.5
0.4
0.5
0.6
7.7
0.81
1.77
6.06

2.62
2.65
2.27
2.62
2.45
28.39

32
32
32
32
32
31
0.64
1.33
6.06

2.74
2.79
2.45
2.48
2.53
28.48
0.48
1.45
1.54

0.58
0.56
0.54
0.44
0.65
9.34
30
29
30

30
30
30
30
30
30
0.73
1.59
6.2

2.67
2.67
2.36
2.62
2.49
28.43
0.56
1.57
2.27

0.6
0.47
0.56
0.44
0.71
9.51

Control/nonintervention
6-week followup
3-month followup
Time 2
Time 3
𝑁 Mean
SD
𝑁 Mean
SD

0.5 32
1.4 30
2.3 32

0.6
0.5
0.6
0.5
0.7
8.9

Posttest
Time 0
Time 1
Mean SD 𝑁 Mean SD

Pretest

(b) Continued.

20
20
20

20
20
20
20
20
20

0.68
1.05
5.55

3.08
2.97
2.69
2.29
2.84
31.9

26
26
26
26
26
26

0.67
1.48
5.5

3.02
2.97
2.53
2.36
2.74
31.9

0.54
1.64
1.84

0.54
0.54
0.61
0.45
0.75
7.68

Intervention
6-week followup
Time 5
𝑁 Mean
SD

0.5 26
1.4 25
2.2 26

0.5
0.4
0.5
0.5
0.6
7.3

Posttest
Time 4
𝑁 Mean SD

24
23
24

24
24
24
24
24
24

0.66
1.39
4.79

2.95
2.89
2.51
2.45
2.72
30.27

0.57
1.5
2.04

0.55
0.55
0.59
0.56
0.69
7.31

3-month followup
Time 6
𝑁 Mean
SD
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Mean value
Mean value

Depressive symptom score
1.6
1.4
1.2
1

2.8
2.7
2.6
2.5
2.4

Rosenberg global self-esteem

0

1

2

26

1.3

24

1.2
0

1

Mean value
Mean value

Interpersonal relation

0.8
0.75
0.7
0.65
0.6

3

2

2
Time

Treatment
Intervention
Wait-list

2.4
Substance use

1
Time

2

1

Emotional support

3

2

3

Substance abuse
1.7
1.6
1.5
1.4
1.3

0

1

2
Time

Treatment
Intervention
Wait-list

2

Positive reframing

3.4
3.2
3
2.8
2.6

Self-blame

Time

1
Time

3
2.75
2.5
2.25
2
0

0

3

3
2.8
2.6
2.4
Pain and fatigue

3

Stress management
2.6
2.5
2.4
2.3

0

6.4
6.2
6
5.8
1

2.6

Spirituality

3
2.9
2.8
2.7
2.6
2.5
2.4

Physical dependency

0

2.8

Time

Time
3
2.9
2.8
2.7
2.6

3

3.3
3.2
3.1
3
2.9

Body image and sexual self-esteem
1.5
30
1.4
28

3

Instrumental support

Active coping

Loneliness
2.7
2.6
2.5
2.4
2.3

Treatment
Intervention
Wait-list

3

0

1

2

3

Time
Treatment
Intervention
Wait-list

Figure 1

unstable over time. Please see Figure 1 for information on the
mean curves on covariates, for example, physical dependency,
substance abuse, and pain and fatigue.
From Table 3, we found that there was a significant
interaction effect of treatment by time on depression symptoms scores (𝑃 < 0.0001), indicating the efficacy of the
intervention program. Furthermore, the plot for depression
symptoms scores in Figure 1 shows a sharp decrease from
the pretest to posttest and that is stabilized at three-month
followup in the intervention group. On the other hand,
the mean curve is flat over time in the control group. For
coping skills,we found a series of significant treatment-bytime interaction effects: substance use (𝑃 = 0.028); emotional
support (𝑃 = 0.005); positive reframing (𝑃 = 0.002); andselfblame (𝑃 = 0.0004). We did not find enough evidence to
support hypothesis 2 on active coping (𝑃 = 0.325) and
instrumental support (𝑃 = 0.144), respectively. For health
behavior, we found significant interaction treatment-by-time
effects on all three selected sub-scales as follows: spirituality
(𝑃 < 0.0001); interpersonal relations (𝑃 = 0.0002); and
stress management (𝑃 = 0.028). We also found strong support for hypothesis 2 on loneliness when testing the interaction treatment-by-time effect (𝑃 < 0.0001). Testing of
the interaction treatment-by-time effect for body image and
sexual self-esteem also indicated a significant interaction

(𝑃 = 0.013). However, testing of the interaction treatmentby-time effect for global self-esteem (𝑃 = 0.1292) indicated
that the interaction effect was insignificant (see Table 3).
Regarding the effect size difference between the groups,
overall, depressive symptom score, loneliness, and spirituality
were strong, ranging from 0.1 to 0.16; interpersonal relations,
self-blame, positive reframing and emotional support were
fairly strong, ranging from 0.06 to 0.09; substance use, stress
management, and body image and sexual self-esteem were
moderate, ranging from 0.04 to 0.05; and active coping,
instrumental support, and global self-esteem were fairly
weak, ranging from 0.01 to 0.025 (see Table 3).
We also investigated the covariates—physical dependency, substance abuse problem, and pain and fatigue. We
found that substance abuse and the fatigue scales were
significant, and thus we included them in the multivariable
model for association analysis (see below).
When examining the associated effects of each secondary
outcome on the depression symptom score, the slope testing
results showed that five of six selected coping sub-scales were
significantly associated with changes in depressive symptom
scores: substance use [𝐹(1, 208) = 4.31, 𝑃 = 0.039, partial
𝜂2 = 0.065]; emotional support [𝐹(1, 209) = 31.65, 𝑃 <
0.0001, partial 𝜂2 = 0.089]; instrumental support [𝐹(1, 209) =
7.69, 𝑃 = 0.006, partial 𝜂2 = 0.024]; positive reframing
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Table 3: Statistical inference on the interaction effect between time and treatment. The analyses are based on the data for the first four time
points. That is, intervention group completed the study, and wait-list group completed the control period time of the study.
Measures
Primary outcome
Depressive symptom score
Secondary outcomes
(i) Coping and problem-solving
(a) Active coping
(b) Substance use
(c) Emotional support
(d) Instrumental support
(e) Positive reframing
(f) Self-blame
(ii) Health behavior
(a) Spirituality
(b) Interpersonal relation
(c) Stress management
(iii) Loneliness
(iv) Rosenberg self esteem
(v) Body image and sexual self-esteem
Covariates
(i) Physical dependency
(ii) Substance abuse
(iii) Pain and fatigue

𝐹-statistic

𝑃 value

Partial 𝜂2

9.51

<0.0001

0.101

1.16
3.11
4.37
1.82
5.00
6.28

0.3246
0.0275
0.0052
0.1444
0.0023
0.0004

0.017
0.046
0.056
0.025
0.060
0.065

13.60
6.84
3.11
9.44
1.91
3.70

<0.0001
0.0002
0.0275
<0.0001
0.1292
0.0127

0.155
0.086
0.036
0.11
0.0248
0.042

2.44
0.39
2.75

0.0655
0.7610
0.0436

0.034
0.006
0.040

[𝐹(1, 209) = 20.42, 𝑃 < 0.0001, partial 𝜂2 = 0.008]; and selfblame [𝐹(1, 209) = 58.92, 𝑃 < 0.0001, partial 𝜂2 = 0.104].
Active coping was insignificantly associated with changes in
depressive scores [𝐹(1, 208) = 1.92, 𝑃 = 0.168, partial
𝜂2 = 0.002]. We also found that all three of the selected
sub-scales in health behavior were significantly associated
with the changes in depressive symptom scores: spirituality
[𝐹(1, 209) = 61.23, 𝑃 < 0.0001, partial 𝜂2 = 0.159];
interpersonal relations [𝐹(1, 209) = 18.05, 𝑃 < 0.0001, partial
𝜂2 = 0.058]; and stress management [𝐹(1, 209) = 38.77,
𝑃 < 0.001, partial 𝜂2 = 0.093]. Furthermore, loneliness was
strongly associated with the changes in depressive symptom
scores, its slope testing has [𝐹(1, 209) = 84.32, 𝑃 < 0.0001,
partial 𝜂2 = 0.215]; as has body image and sexual self-esteem
[𝐹(1, 209) = 9.41, 𝑃 = 0.002, partial 𝜂2 = 0.094]. Global selfesteem was barely significantly associated with the changes in
depressive scores, and its slope testing has [𝐹(1, 209) = 3.84,
𝑃 = 0.05, partial 𝜂2 = 0.0026].
The results of the multivariable model which includes
eleven secondary outcomes that are singly significantly associated with the primary outcome of depressive symptoms
indicate that seven variables remained significant model.
We found loneliness to be the strongest in contributing
to changes in the outcome of depressive symptoms with
a positive association, its standardized estimate of 0.3827.
This means that for every 1 point increase in loneliness,
we would expect to see a 0.38 increase in the depressive
symptom score. Interpersonal relations came in as the second
strongest with a positive association, its standardized estimate

of 0.3377. With this unexpected finding we found that for
every 1 point score increase in interpersonal relations there
was roughly a 0.34 score increase in the depression symptom
score. The third largest contributor was spirituality with a
negative association, its standardized estimate of −0.2799.
For every 1 point increase in spirituality, we would expect to
see a 0.28 score decrease in the depression score. Emotional
support and self-blame came in fourth and fifth, with their
negative/positive association, the standardized estimates of
−0.135 and 0.144, respectively. Their interpretations were
opposite; for every 1 point increase in emotional support, we
would expect roughly a 0.14 score decrease in the depression
symptom score, and for every 1 point increase in selfblame we would expect roughly a 0.14 score increase in the
depression symptom score. Sixth was positive reframing with
a negative association, its standardized estimate of −0.077.
Every 1 point increase in positive reframing contributed
roughly a 0.077 decrease to the depression score. Seventh was
substance use with a fairly weak association, its standardized
estimate of 0.07. Every 1 point increase in substance use
contributed roughly a 0.07 score increase to the depression
score.
6.1. Postprogram Focus Group Feedback. We conducted focus
groups at the end of the 14-week program with each therapy
group. We asked participants to evaluate the program in
terms of content, process, and outcomes. With regard to content all of the programmatic content was viewed as important;
however, it was suggested that content related to sexuality
be made optional. Process feedback strongly suggested that
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women in the groups wanted more time for personal sharing
during each session and that overall there was a belief that
a 14-week program was too short to adequately cover all
important topics. Finally, we received overwhelmingly strong
and positive feedback about the quality of the program
and the transformative impact it had had on women’s lives.
Women made many positive changes during the program
including leaving abusive relationships, expanding their
social networks, and achieving gainful employment.

7. Discussion
Depression in WPD is a common problem; that is, associated
with significant morbidity and mortality. Although several
nonpharmacologic treatments for depression are available,
we are unaware of any that specifically address the psychosocial issues faced by WPD cross-disability. The HP program
offers a novel approach to addressing depression in WPD as
a cooccurring condition that draws on both mental health
theories and peer empowerment approaches to treatment.
Despite randomization we found differences at baseline on many variables between the intervention and control groups including a statistically significant difference
in depressive symptoms with the treatment group having
higher depressive symptom scores. This is a limitation of
our study. Despite this limitation our findings provide initial
support for the HP program’s efficacy in treating depressive
symptoms as well as improvements in selected secondary outcomes of coping (substance use, emotional support, positive
reframing, self-blame), health behavior (spirituality, stress
management), self-esteem (body and sexual), and loneliness,
all important for WPD. In addition, the pattern of results
suggests that HP’s four core skill areas may explain these
outcomes. Identifying and addressing thoughts and beliefs
and identifying and managing emotions (the first two skill
areas) are foundational skills to improving interpersonal
skills and developing and strengthening coping and problemsolving skills (the last two skill areas). It is these latter two
skill areas that are manifested most clearly in the associations
between our coping, health behavior, body and sexual selfesteem, and loneliness variables and our outcome variable
of depressive symptoms. Interpersonal skills can be said to
correspond to the variables emotional support and loneliness
while coping and problem-solving can be said to correspond
to the variables substance abuse, positive reframing, selfblame, spirituality, and stress management.
Three variables were insignificant including active and
instrumental coping and global self-esteem. Active coping
was not significantly associated with an improvement in
depressive symptom scores suggesting that it may lack relevance to the primary outcome of depressive symptoms.
Similarly, instrumental coping although singly significantly
associated with an improvement in depressive symptoms
scores proved insignificant in the multivariate model suggesting it may also lack relevance to the primary outcome
when other associated effects are considered jointly. Another
possible consideration is the impact of the use of acceptance
as a coping strategy. Examination of active and instrumental
coping items points to active change efforts, forgoing the
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possibility of acceptance as a coping strategy (i.e., “doing
something about the situation” (active coping) and “getting
help and advice from other people” (Instrumental coping).
It is possible that acceptance, which was taught as a part
of the managing emotions portion of HP, was used by
participants as a balancing strategy along with more active
strategies resulting in a dilution of the strength of active
and instrumental coping approaches. With regard to global
self-esteem, improvement in this secondary outcome in the
intervention group coupled with the lack of significance
suggests that this program element needs strengthening.
Focus group participant feedback suggested that a longer
program allowing for more in-depth exploration of content
would be stronger. This may be an example of program
content that was not covered in sufficient depth.
In response to the troubling finding that the Interpersonal
Relations sub-scale of the Health Promoting Lifestyle Profile
II was both significantly improved and associated with an
increase in depressive symptom scores we examined the
items and the pattern of responses of this scale. In doing
so we found that participants in the intervention group
strongly improved relative to the control group on every item.
Although some of the items seem to be unarguably positive
(e.g., “maintaining meaningful and fulfilling relationships
with others), others were not necessarily so. For example,
“discuss my problems and concerns with people close to
me” may be positive in some instances but not in others.
Discussing problems with others repeatedly without movement or change could be a sign of dependency. Similarly,
discussing problems with others who are close to you but not
very supportive could prove detrimental. Therefore some of
the items on the interpersonal relations sub-scale, although
in theory measuring positive health behaviors, may not be
always positive. This may explain at least in part why the
improvement in interpersonal relations was associated with
an increase in depressive symptoms.
In addition to statistically significant results we also
observed significant changes in women’s lives during our
study. Following study completion, participants in one rural
town subsequently went on to establish a mental health dropin center. Others started their own HP groups. Although
we did not formally measure changes in employment, anecdotally, we also observed that many women who were
experiencing challenges staying employed reported positive
changes in sustaining employment. One woman started her
own business. Others sought gainful and meaningful employment. Word of this effect eventually led to establishment of a
contract with Oregon Vocational Rehabilitation for services
to unemployed WPD with cooccurring depression. We developed an untested employment version of the HP program
for this purpose. Depression and employment outcomes of
the first year of that program look promising. Of the 14
WPD who completed exit interviews a mean 15.6 point
drop in CES-D scores was observed. In addition, of those
14 chronically unemployed women, 8 obtained employment
suggesting that testing of the employment version of the
HP program may be appropriate at some point in the
future. In addition to this employment version, the original
HP program (described in this paper) continues to be

Rehabilitation Research and Practice
offered to WPD with cooccurring depression in two Oregon
communities.
In addition to our work with the original HP program, we
are currently engaged in work developing a HP peer facilitator training program to standardize the preparation of peers
trained to implement the program using CBPR principles.
It is our hope to disseminate the HP program to expand
treatment options for WPD with cooccurring depression
and in particular to increase options for treatment within
disability communities. This approach is consistent with the
RE-AIM framework, a model intended to enhance the quality,
speed, and public health impact of efforts to translate research
into practice in five steps including reaching your intended
target population, demonstrating efficacy, adoption by target
settings or institutions, implementation (i.e., consistency of
delivery of intervention), and maintenance of intervention
effects in individuals and settings over time [64]. We are
currently focused on the adoption and implementation components of the model.
In conclusion, our study provides support for the efficacy
of the HP program in addressing depressive symptoms
in WPD and some selected secondary outcomes. Because
it is specifically designed for WPD, the HP program has
potential to provide WPD with an alternative treatment
option for depressive symptoms, that is, culturally relevant
and accessible. We hope that disability service organizations,
WPD community groups, and rehabilitation counselors find
this freely available program useful to their work.
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